Clinical Trial Update: Gemcitabine (GFF) in Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Gemcitabine (GFF) in patients with metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: CONKO-Studiengruppe | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: COMPLETED